Congenital lipodystrophy induces severe osteosclerosis.

Area of Science:

• Endocrinology
• Skeletal Biology
• Metabolic Diseases

Background:

• Berardinelli-Seip congenital generalized lipodystrophy is linked to increased bone mass, indicating a role for adipose tissue in skeletal regulation.
• Limited mechanistic understanding exists regarding the interaction between fat tissue and bone metabolism.

Purpose of the Study:

• To investigate the mechanistic link between fat tissue and skeletal regulation.
• To determine the role of adipocyte-derived factors in modulating bone mass.

Main Methods:

• Generation of "fat-free" (FF) mice lacking visible adipose tissue.
• Analysis of bone parameters (trabecular and cortical bone volume) and glucose metabolism in FF mice.
• Rescue experiments involving transplantation of adipocyte precursors and fat depots from wild-type and knockout mice.
• Assessment of the impact of adiponectin and leptin deficiencies on the skeletal phenotype.

Main Results:

• FF mice exhibit significantly enhanced trabecular and cortical bone volume due to robust osteoblastic activity.
• Despite diabetes and altered insulin levels, the skeletal phenotype of FF mice was not normalized by glucose tolerance correction.
• Transplantation of adipocyte precursors or fat depots fully rescued the skeletal phenotype of FF mice.
• Transplantation of fat from adiponectin and leptin double knockout mice failed to normalize FF bone, unlike fat from wild-type mice.

Conclusions:

• Adipocyte-derived products are critical regulators of bone mass.
• Leptin and adiponectin signaling are key pathways through which fat tissue influences skeletal homeostasis.
• A deficiency in leptin and adiponectin may contribute to the increased bone mass observed in Berardinelli-Seip patients.